Today, a Director at Medical Transcription Billing (NASDAQ: MTBC), John N. Daly, sold shares of MTBC for $47K.
See today’s analyst top recommended stocks >>
Based on Medical Transcription Billing’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $8.68 million and quarterly net profit of $195.3K. In comparison, last year the company earned revenue of $7.78 million and had a GAAP net loss of $1.69 million. Currently, Medical Transcription Billing has an average volume of 103.8K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medical Transcription Billing Corp. is a healthcare information technology company, which engages in the provision of integrated suite of proprietary web-based solutions. Its products and services include electronic health records, practice management, patient engagement, medical billing, value added, consultancy, medical transcription, and business intelligence. The company was founded by Mahmud Ul Haq on September 28, 2001 and is headquartered in Somerset, NY.
